KK
OCUL icon

KLP Kapitalforvaltning’s Ocular Therapeutix OCUL Stock Holding History

KLP Kapitalforvaltning’s Portfolio OCUL Stock Details OCUL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$355K Hold
36,100
– – ﹤0.01% 1663
2026
Q1 		$306K Buy
36,100
+2,400
+7% +$22.9K ﹤0.01% 1657
2025
Q4 		$409K Buy
33,700
+10,000
+42% +$121K ﹤0.01% 1505
2025
Q3 		$277K Hold
23,700
– – ﹤0.01% 1684
2025
Q2 		$220K Buy
23,700
+6,300
+36% +$49.3K ﹤0.01% 1747
2025
Q1 		$128K Hold
17,400
– – ﹤0.01% 1928
2024
Q4 		$149K Buy
+17,400
New +$170K ﹤0.01% 1943

Other funds holding OCUL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
SR
Summer Road West Palm Beach, Florida $161M AUM 27.24% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

KLP Kapitalforvaltning's OCUL Position: Q2 2026 in Review

KLP Kapitalforvaltning held its Ocular Therapeutix (OCUL) position steady in Q2 2026 at 36,100 shares worth $355K. The position accounts for ﹤0.01% of the portfolio, ranked #1663.

KLP Kapitalforvaltning first reported a position in OCUL in Q4 2024 and has held it in 7 quarters since. The position peaked at $409K in Q4 2025. 263 funds tracked by Wall St. Rank hold OCUL as of Q2 2026.

  • KLP Kapitalforvaltning held 36,100 shares of Ocular Therapeutix worth $355K as of Q2 2026.
  • KLP Kapitalforvaltning left its Ocular Therapeutix share count unchanged in Q2 2026.
  • Ocular Therapeutix made up ﹤0.01% of KLP Kapitalforvaltning's portfolio in Q2 2026, its #1663 holding.
  • KLP Kapitalforvaltning first reported a position in Ocular Therapeutix in Q4 2024 and has held it in 7 quarters since.
  • KLP Kapitalforvaltning's Ocular Therapeutix position peaked at $409K in Q4 2025.
  • 263 funds tracked by Wall St. Rank held Ocular Therapeutix as of Q2 2026.

Based on KLP Kapitalforvaltning's 13F filing for Q2 2026, filed 12 Aug 2026.